nasal surgery. Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care
Conditions
Interventions
Intervention 1: Intervention group 1 : they received nitroglycerin. The nitroglycerin dose rate of 5 mcg / min every 3 to 5 minutes, then to the extent prescribed by 5 mcg / min was added. Interventio
Treatment - Drugs
Intervention group 1 : they received nitroglycerin. The nitroglycerin dose rate of 5 mcg / min every 3 to 5 minutes, then to the extent prescribed by 5 mcg / min was added.
Intervention group 2 : they received labetalol, the starting dose is 5 mg in labetalol group. And to establish anti-hypertension effect desired, can be 5 to 10 mg every 5 minutes once received
Sponsors
Vice Chancellor for Research, Mashhad University of Medical Science
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: candidate for nasal surgery; American Society of Anesthesiology (ASA) I and II Exclusion criteria: history of cardiovascular disease; history of hypertension; liver or kidney disease and coagulation disorders; hemoglobin below 10 ; receiving aspirin or other anticoagulation's before surgery
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean arterial blood pressure. Timepoint: Before induction, Every 5 minutes to 75 minutes, after induction, during surgery and end of surgery. Method of measurement: Non-invasive monitoring of blood pressure. | — |
Secondary
| Measure | Time frame |
|---|---|
| Volume of bleeding. Timepoint: Before induction, every 5 minutes to 75 minutes, after induction, during surgery and end of surgery. Method of measurement: Total gauze consumption and suction.;Heart rate. Timepoint: Before induction, every 5 minutes to 75 minutes, after induction, during surgery and end of surgery. Method of measurement: Hemodynamic monitoring.;Need for additional drug. Timepoint: Time of measurement: Before induction, every 5 minutes to 75 minutes, after induction, during surgery and end of surgery. Method of measurement: Based on the dose of drug. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMajid Razavi
Mashhad University of Medical Sciences
Outcome results
None listed